MilliporeSigma has signed an agreement with HistoCyte Laboratories, a Tyne, UK-based cell-line technology company, to be the exclusive multinational distributor of HistoCyte’s portfolio of cell-line reference products for immunohistochemistry and in situ hybridization.

Under the agreement, MilliporeSigma will employ its sales, marketing, and e-commerce experience to distribute HistoCyte’s range of pathology slide controls in the US and other select geographies. The controls will be available in cell-microarray blocks. Outside of the select geographies, HistoCyte Laboratories will continue to reach customers through its own channels. Financial details were not disclosed.

Source: MilliporeSigma